as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.52%
Downside
4.64%
Upside
52 Week's Low
52 Week's High
79.38%
Downside
59.54%
Upside
Check Cytomx Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$328.2M
EPS (TTM)
0.074
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.61%
PE Ratio (TTM)
3.98
Industry PE ratio
-3.9281873111782475
P/B Ratio
3.98
PEG Ratio
-1.8
EBITDA
44.7M
Revenue (TTM)
141.1M
Profit Margin
34.01%
Return On Equity TTM
108.21%
Track how Cytomx Therapeutics Inc P/E has moved over time to understand its valuation trends.
Cytomx Therapeutics Inc in the last 5 years
Lowest (1.58x)
March 31, 2025
Industry (-3.93x)
September 17, 2025
Today (3.98x)
September 17, 2025
Highest (14.22x)
June 30, 2024
Today’s Price to Earnings Ratio: 3.98x
Compare market cap, revenue, PE, and other key metrics of Cytomx Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
HOLD | $328.2M | -72.7% | 3.98 | 34.01% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Cytomx Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cytomx Therapeutics Inc investment value today
Current value as on today
₹1,64,929
Returns
₹64,929
(+64.93%)
Returns from Cytomx Therapeutics Inc Stock
₹60,331 (+60.33%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 13 analysts
46.15%
Buy
53.85%
Hold
0.00%
Sell
Based on 13 analysts, 53.85% of analysts recommend a 'HOLD' rating for Cytomx Therapeutics Inc. Average target price of $5.75
Get share price movements and forecasts by analysts on Cytomx Therapeutics Inc.
What analysts predicted
66.26%UPSIDE
Target Price
$5.75
Current Price
$1.94
Analyzed by
13 Analysts
Target
$5.75
Cytomx Therapeutics Inc target price $5.75, a slight upside of 66.26% compared to current price of $1.94. According to 13 analysts rating.
Search interest for Cytomx Therapeutics Inc Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 6.1%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 92.4%
Profit Down
Netprofit is down for the last 2 quarters, 23.52M → -154.0K (in $), with an average decrease of 100.7% per quarter
Price Dip
In the last 7 days, CTMX stock has moved down by -5.3%
Revenue Fall
Revenue is down for the last 2 quarters, 50.91M → 18.65M (in $), with an average decrease of 63.4% per quarter
Organisation | Cytomx Therapeutics Inc |
Headquarters | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Dr. Sean A. McCarthy DPHIL |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Dawn Benson | Senior Vice President of Quality & Product Manufacturing |
Mr. Christopher W. Ogden | SVP & Chief Financial Officer |
Dr. Yu-Waye Chu M.D. | Chief Medical Officer |
Mr. Lloyd A. Rowland Jr., J.D. | Senior VP, General Counsel, Chief Compliance Officer & Secretary |
Ms. Danielle Olander-Moghadassian | Senior VP & Chief Human Resources Officer |
Ms. Leslie Robbins J.D. | Senior Vice President of Intellectual Property |
Dr. Stephanie Robertson Ph.D. | Senior Vice President of Alliances & Program Leadership |
Dr. Sean A. McCarthy DPHIL | Chairman & CEO |
Dr. Marcia P. Belvin Ph.D. | Senior VP & Chief Scientific Officer |
Cytomx Therapeutics Inc share price today is $1.94 as on at the close of the market. Cytomx Therapeutics Inc share today touched a day high of $2.03 and a low of $1.93.
Cytomx Therapeutics Inc share touched a 52 week high of $3.1 on and a 52 week low of $0.4 on . Cytomx Therapeutics Inc stock price today i.e. is closed at $1.94,which is 37.32% down from its 52 week high and 385.00% up from its 52 week low.
Cytomx Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Cytomx Therapeutics Inc (CTMX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Cytomx Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cytomx Therapeutics Inc share’s latest price of $1.94 as on September 18, 2025 at 1:29 am IST, you will get 5.1546 shares of Cytomx Therapeutics Inc. Learn more about
fractional shares .
Cytomx Therapeutics Inc stock has given -72.7% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?